Condition

Esophageal Adenocarcinoma (EAC) (1)

Esophageal Squamous Cell Carcinoma (ESCC) (1)

Gastroesophageal Junction Carcinoma (GEJC) (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Merck Sharp & Dohme LLC (1)

Collaborator

Intervention

5-fu (1)

cisplatin (1)

leucovorin (1)

levoleucovorin (1)

oxaliplatin (1)

pembrolizumab (1)

placebo (1)

radiotherapy (1)

Study Documents

Intervention Type

biological (1)

drug (1)

radiation (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

esophageal adenocarcinoma (eac)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Esophageal Squamous Cell Carcinoma (ESCC), Gastroesophageal Junction Carcinoma (GEJC), Esophageal Adenocarcinoma (EAC) Trial in

Recruiting

Esophageal Squamous Cell Carcinoma (ESCC)
+2 more

pembrolizumab
+7 more

Long Beach, California
+158 more

Jan 19, 2023